FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Leuprolide Acetate (Lupron Depot; Lupron Depot Ped) Injection
Status: Resolved
»Duration of Shortage: 12/10/2019 - 01/09/2020
»Therapeutic Categories: Endocrinology/Metabolism; Oncology

Expand all

Abbvie (Revised 01/09/2020)

Company Contact Information:
800-621-1020

Presentation
  • Lupron Depot 3.75 mg PDS kit (NDC 0074-3641-03)
  • Lupron Depot Ped, 3Month, 11.25 mg kit (NDC 0074-3379-03)
  • Lupron Depot Ped, 3Month, 30 mg kit (NDC 0074-9694-03)
  • Lupron Depot, 3Month, 11.25 mg PDS kit (NDC 0074-3663-03)
  • Lupron Depot, 3Month, 22.5 mg PDS kit (NDC 0074-3346-03)
  • Lupron Depot, 4Month, 30 mg PDS kit (NDC 0074-3683-03)
  • Lupron Depot, 6Month 45 mg PDS kit (NDC 0074-3473-03)
Note:
  • N/A

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English